Back to list

Journal publications, Local data


  • Clinical Experience with BIAsp 30: Results from the Philippine Cohort of the Global A1chieve Study Mary Anne Lim-Abrahan, Anand B Jain, Susan Yu-Gan, Leorino M. Sobrepena, Veronica A. Racho
    Key findings: Safety, effectiveness and health-related quality of life were assessed in 1,252 subjects from the Philippine cohort of the A1chieve study who were treated with the premixed insulin analogue biphasic insulin aspart 30 (BIAsp 30). This subset analysis of the study showed that administration of BIAsp 30 among Filipino patients (both insulin-naïve and prior insulin users) improved glycemic control without concomitant risk of hypoglycemia or weight gain. Other findings at the end of the study (24 weeks) include reductions in systolic blood pressure, total cholesterol, LDL cholesterol and triglycerides in the treated subjects.

    Philippine Journal of Internal Medicine. 2014;52(3):1-10

  • Biphasic insulin aspart 30 improved glycemic control in Chinese patients with type 2 diabetes poorly controlled on oral glucose-lowering drugs: a subgroup analysis of the A1chieve study Chen Liming, Xing Xiaoyan, Lei Minxiang, Liu Jie, Shi Yongquan, Li Pengqiu, Qin Guijun, Li Chengjiang, Li Yukun, Wang Qing, Gao Tianshu, Hu Ling, Wang Yangwei, Yang Wenying
    Key findings: In a subgroup analysis from the A1chieve study of 4,100 Chinese patients with type 2 diabetes who were poorly controlled on oral glucose-lowering drugs (OGLDs), treatment with biphasic insulin aspart 30 alone or in combination with OGLDs was shown to improve glycemic control with low risk of hypoglycemia.

    Chinese Medical Journal. 2014;127(2):208-212



  • Health status at baseline, complications associated with diabetes, country specific characteristics vs global findings. Leon Litwak et al.

    Journal of Argentinean Diabetes Society. (Revista Sociedad Argentina de Diabetes) 2012, Volume 46, Issue 2, Pages 49-56

  • Switching from human insulin to insulin analogs improve HbA1c and reduce hypoglycemias in type 2 diabetic patients: Data from the A1chieve Algerian cohort Z. Arbouche, A. Lezzar, A. Salah-Mansour, S. Zinai

    Médecine des Maladies Métaboliques 2012, Volume 6, Issue 6, Pages 511-518

Back to list

Search this site

Insulin Management Programme

The Progress in Insulin Management Resource Centre is a global, online educational platform created to help healthcare professionals and diabetes specialists to optimize their management of patients with type 1 and type 2 diabetes. Its key features include a free, online educational program on insulin management (10 courses in 3 content areas), selected and commented articles, summaries, infographics, webcasts, interviews, and e-learning modules.

You can register for free, start as many courses as you want simultaneously and get a certificate after course completion.

A1chieve Resource Centre Expert Panel

  • Philip Home

    Professor Philip Home

    Philip Home is Professor of Diabetes Medicine at Newcastle University and consultant physician in Newcastle, UK. Professor Home is Chairman of A1chieve® Global Advisory Board.

    Read more »

A1chieve results from bangladesh and ASEAN countries

Now available in the Resource Centre, the just published supplement to Diabetes Research and Clin...

Read more »